Antoniya Todorova, MD, PhD

Dr. Todorova is a board-certified neurologist with over 15 years of clinical and research experience in neurodegenerative disorders and demyelinating diseases. She obtained her PhD degree with a thesis on Quality of life in patients with Parkinson’s disease and was involved in academic and clinical research. Dr. Todorova worked as a Clinical Research Fellow at King's College Hospital, London and during this period she was involved in academic research focused on non-motor symptoms and continuous drug treatment in Parkinson's disease. She contributed to 14 publications in international medical journals, as well as 16 abstracts/ oral presentations in medical conferences.

She has been an Investigator in more than 20 clinical drug trials in Parkinson’s Disease, Alzheimer disease, Multiple Sclerosis and Migraine.

Her pharmaceutical industry expertise is focused on the neurosciences across Phase I-IV of clinical development, mainly in Parkinson’s disease, Alzheimer’s disease and Multiple sclerosis.

Based in Brussels, Belgium.